Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIWIT: Ultrasound to Predict Relapse After Infliximab Discontinuation in RA
NCT02770794Phase 4Completed
- Sponsor
- Chiba University
- Start
- Apr 2016
- Primary completion
- Aug 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in rheumatoid arthritis (RA), sponsored by Chiba University. Started Apr 2016; status: completed.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02770794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02770794.